drugset / Trial / NCT00352495

Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma

NCT00352495

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as vinblastine and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of vinblastine when given together with carboplatin in treating young patients with newly diagnosed or recurrent low-grade glioma.

Timeline

Start
2006-06
Primary completion
2011-09
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule 140 mg/m2 Intravenous
Subject Carboplatin Small molecule 300 mg/m2 Intravenous
Subject Carboplatin Small molecule 400 mg/m2 Intravenous
Subject Carboplatin Small molecule 500 mg/m2 Intravenous
Subject Vinblastine Small molecule 3.5 mg/m2 Intravenous
Subject Vinblastine Small molecule 4 mg/m2 Intravenous
Subject Vinblastine Small molecule 4.5 mg/m2 Intravenous